Investor Overview
BetterLife is an emerging biotech company creating and clinically validating 2nd-Generation Non-Hallucinogenic Psychedelic compounds and drug delivery mechanisms for clinical trials and commercialization of cutting-edge treatments for mental disorders.
Corporate Summary
Based out of Vancouver, Canada, we have developed strategic relationships across Canada, United States and Switzerland to develop, advance, and deliver on patient-friendly medicines that will help reduce the mental health footprint.
Our Market Differentiation
Meaning comes from execution plus adoption of concept-to-delivery solutions to gain traction with transparency, dependability, and authority leading to a widespread adoption for the unmet needs.
Our Uniqueness
… resides in our Patient-Friendly solutions that will help us create sustainable long-term value for patients, shareholders, and stakeholders.
BetterLife Pharma’s Patient-Friendly approach is bringing the most amount of good to the greatest number of people in the most efficient way! This is based on four key principles.
Patient - Friendly
Accessible
In Home Treatment
Affordable
Not Cost Prohibitive
Applicable
Patent Protected
Allowable
Not Scheduled/Regulated
Our Uniqueness
… resides in our Patient-Friendly solutions that will help us create sustainable long-term value for patients, shareholders, and stakeholders.
BetterLife Pharma’s Patient-Friendly approach is bringing the most amount of good to the greatest number of people in the most efficient way! This is based on four key principles.
Patient - Friendly
Accessible
Easily obtained by many patients or sufferers.
Affordable
Cost-effective medicines or therapies.
Adaptable
Can complement standard of care therapies.
Allowable
Not restricted by any laws, policies, and or authorities.
